أحدث المنشورات
Area Under The Curve Of Methotrexate And Creatinine Clearance Are Outcome-Determining Factors In Primary Cns Lymphomas
Bj Cancer 2004; 90, 353-358.
Ajm Ferreri, E Guerra, M Regazzi, F Pasini, A Ambrosetti, A Pivnik, A Calderoni, M Spina, A Brandes, F Ferrarese, A Rognone, S Govi, S Dell’oro, M Locatelli, E Villa, M Reni.
Colorectal Carcinoma In Children And Adolescents: The Experience Of The Istituto Nazionale Tumori Of Milan, Italy
Pediatr Blood Cancer. 2008 Mar;50(3):588-93.
Ferrari A, Rognone A, Casanova M, Zaffignani E, Piva L, Collini P, Bertario L, Sala P, Leo E, Belli F, Gallino G.
Carbohydrate Antigen 19-9 Change During Chemotherapy For Advanced Pancreatic Adenocarcinoma
Cancer. 2009 Jun 15;115(12): 2630-9.
Reni M, Cereda S, Balzano G, Passoni P, Rognone A, Fugazza C, Mazza E, Zerbi A, Di Carlo V, Villa E.
Outcome Of Upfront Combination Chemotherapy Followed By Chemoradiation For Locally Advanced Pancreatic Adenocarcinoma
Cancer Chemother Pharmacol. 2009 Nov;64(6):1253-9. Epub 2009 Apr 21.
Reni M, Cereda S, Balzano G, Passoni P, Rognone A, Zerbi A, Nicoletti R, Mazza E, Arcidiacono Pg, Di Carlo V, Villa E.
Weekly Epirubicin As Salvage Therapy In Patients With Gemcitabine-Resistant Advanced Pancreatic Cancer
J Chemother. 2009 Dec;21(6):698-700.
Cereda S, Rognone A, Mazza E, Fugazza C, Ceraulo D, Villa E, Reni M.
An Italian Study On Treatment Trends And Outcomes Of Patients With Stage Iii Pancreatic Adenocarcinoma In The Gemcitabine Era Is It Time To Change?
Anticancer Drugs. 2010 Apr;21(4):459-64.
Reni M, Sartori N, Mambrini A, Berardi R, Passardi A, Milella M, Cereda S, Tronconi Mc, Aprile G, Cordio S, Pasetto Lm, Rognone A, Pederzoli P, Falconi M.
Treatment Trends In Metastatic Pancreatic Cancer Patients: Is It Time To Change?
Dig Liver Dis. 2011 Mar;43(3):225-30.
Reni M, Pasetto Lm, Passardi A, Milella M, Mambrini A, Cereda S, Aprile G, Tronconi Mc, Berardi R, Cordio S, Sartori N, Rognone A, Pederzoli P, Falconi M.
Xeliri Or Folfiri As Salvage Therapy In Advanced Pancreatic Cancer
Anticancer Res. 2010 Nov;30(11):4785-90.
Cereda S, Reni M, Rognone A, Ghidini M, Belli C, Longoni S, Fugazza C, Brioschi M, Nicoletti R, Balzano G, Passoni P, Villa E.
Treatment Trends In Metastatic Pancreatic Cancer Patients: Is It Time To Change?
Dig Liver Dis. 2011 Mar;43(3):225-30. Epub 2010 Nov 2.
Reni M, Pasetto Lm, Passardi A, Milella M, Mambrini A, Cereda S, Aprile G, Tronconi Mc, Berardi R, Cordio S, Sartori N, Rognone A, Pederzoli P, Falconi M.
A Randomized Phase Ii Trial Of Two Different 4-Drug Combinations In Advanced Pancreatic Adenocarcinoma: Cisplatin, Capecitabine, Gemcitabine Plus Either Epirubicin Or Docetaxel (Pexg Or Pdxg Regimen)
Cancer Chemother Pharmacol. 2011 May 28.
Reni M, Cereda S, Rognone A, Belli C, Ghidini M, Longoni S, Fugazza C, Rezzonico S, Passoni P, Slim N, Balzano G, Nicoletti R, Cappio S, Doglioni C, Villa E.
Adjuvant Pefg (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) Or Gemcitabine Followed By Chemoradiation In Pancreatic Cancer: A Randomized Phase Ii Trial
Redattore Del Capitolo Per Il Paziente Sui Tumori Cerebrali Di Start Oncology In Lingua Italiana.
Reni M, Balzano G, Aprile G, Cereda S, Passoni P, Zerbi A, Tronconi Mc, Milandri C, Saletti P, Rognone A, Fugazza C, Magli A, Di Muzio N, Di Carlo V, Villa E. Ann Surg Oncol. 2012 Jul;19(7):2256-63.
Second-Line Therapy In Advanced Biliary Tract Cancer: What Should Be The Standard?
Crit Rev Oncol Hematol. 2013 Nov;88(2):368-74. Epub 2013 Jun 17.
Cereda S, Belli C, Rognone A, Mazza E, Reni M.
Cancer Genetic Counseling And Quality Of Life: The Effect Of Coping Strategies And Psychopathological Symptoms During Pre-Test Genetic Counseling
Recenti Prog Med. 2015 Aug;106(8):380-4. Doi: 10.1701/1960.21304. Italian.
Di Mattei Ve, Duchini E, Zucchi P, Patricelli Mg, Rognone A, Di Pierro R, Zambetti M, Sarno L.
Personalized Risk-Benefit Ratio Adaptation Of Breast Cancer Care At The Epicenter Of Covid-19 Outbreak
Oncologist. 2020 Jul;25(7):E1013-E1020. Doi: 10.1634/Theoncologist.2020-0316. Epub 2020 May 26
Viale G, Licata L, Sica L, Zambelli S, Zucchinelli P, Rognone A, Aldrighetti D, Di Micco R, Zuber V, Pasetti M, Di Muzio N, Rodighiero M, Panizza P, Sassi I, Petrella G, Cascinu S, Gentilini Od, Bianchini G. Version 2.
Pondx: Real-Life Utilization And Decision Impact Of The 21-Gene Assay On Clinical Practice In Italy
Npj Breast Cancer. 2021 May 5;7(1):47. Doi: 10.1038/S41523-021-00246-4.
Cognetti F, Masetti R, Fabi A, Bianchi G, Santini D, Rognone A, Catania G, Angelucci D, Naso G, Giuliano M, Vassalli L, Vici P, Scognamiglio G, Generali D, Zambelli A, Colleoni M, Tinterri C, Scanzi F, Vigna L, Scavina P, Gamucci T, Marrazzo E, Scinto Af, Berardi R, Fabbri Ma, Pinotti G, Franco D, Terribile Da, Tonini G, Cianniello D, Barni S.
